AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Nykode Therapeutics ASA

Major Shareholding Notification Oct 14, 2025

3695_mrq_2025-10-14_8678c747-72d5-4e4f-b80c-e19831161573.html

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

Disclosure of Large Shareholding - Nykode Therapeutics ASA

Disclosure of Large Shareholding - Nykode Therapeutics ASA

Please find the attached notifications as of 10 October 2025 submitted on behalf of The Capital Group Companies, Inc. ("CGC") and SMALLCAP World Fund, Inc. ("SCWF") due to the purchase of shares.

Please note that the notification submitted on behalf of CGC as of 10 October 2025 included SCWF’s holdings.

SCWF is a mutual fund registered in the United States under the Investment Company Act of 1940. SCWF is the legal owner of the 16,387,015 shares held (5.018% of total voting rights and 5.018% of total share capital) as of 10 October 2025. SCWF has granted proxy voting authority to Capital Research and Management Company ("CRMC"), its investment adviser. As noted in the letter, CGC is the parent company of CRMC.

Please see attachments on www.newsweb.no

Talk to a Data Expert

Have a question? We'll get back to you promptly.